Progressive multifocal leucoencephalopathy with magnetic resonance imaging verification and therapeutic trials with interferon

J Neurol. 1987 Aug;234(6):427-9. doi: 10.1007/BF00314091.

Abstract

Progressive multifocal leucoencephalopathy was diagnosed by magnetic resonance imaging (MRI) and brain biopsy in a 44-year-old woman, for whom therapeutic trials with various antiviral agents were made. Despite early diagnosis and treatment, her neurological deterioration and extension of MRI-detectable lesions were not halted for a period of about 8 months. After the introduction of intrathecal beta-interferon therapy, her neurological status and MRI findings became stable and showed minimal improvement. Early diagnosis of this fatal disorder is important and intrathecal interferon therapy should be considered.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Cytarabine / therapeutic use
  • Female
  • Frontal Lobe / pathology
  • Humans
  • Interferon Type I / therapeutic use*
  • Leukoencephalopathy, Progressive Multifocal / drug therapy
  • Leukoencephalopathy, Progressive Multifocal / pathology
  • Leukoencephalopathy, Progressive Multifocal / physiopathology*
  • Magnetic Resonance Imaging
  • Tomography, X-Ray Computed
  • Vidarabine / therapeutic use

Substances

  • Interferon Type I
  • Cytarabine
  • Vidarabine